Weiss Amir
SEC insider (Form 3/4/5 filer). CIK 0001897057. Chief Accounting Officer at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA). 16 reported Form 4/5 transactions since Sep 2024; latest on Aug 21, 2026. Located in TEL AVIV.
Companies Weiss Amir has filed insider reports for
- TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA): Officer, Chief Accounting Officer
Weiss Amir
CIK: 0001897057
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TEVA PHARMACEUTICAL INDUSTRIES LTD
Discretionary Trading P&L
Holdings
Transaction History (16 total)
- Aug 21, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SaleDirect2.5K shares at avg. $37.63$94K - Aug 21, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
ExerciseDirect2.5K shares at avg. $19.61$49K - Aug 21, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SaleDirect6.9K shares at avg. $37.61$261K - May 6, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SaleDirect10.7K shares at avg. $36.00$384K - Mar 5, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
ExerciseDirect3.5K shares- - Mar 4, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
AwardDirectRestricted Share Units
11.3K shares- - Mar 4, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
ExerciseDirect10.7K shares- - Mar 4, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
ExerciseDirect5.7K shares- - Mar 3, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
ExerciseDirect5.2K shares- - Dec 16, 2025TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SaleDirect12.3K shares at avg. $30.20$372K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 21, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Sale | 2,500 | $37.63 | $94,077 | Direct |
| Aug 21, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Exercise | 2,500 | $19.61 | $49,025 | Direct |
| Aug 21, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Sale | 6,945 | $37.61 | $261,224 | Direct |
| May 6, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Sale | 10,679 | $36.00 | $384,444 | Direct |
| Mar 5, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Exercise | 3,537 | - | $0 | Direct |
| Mar 4, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Award Restricted Share Units | 11,280 | - | - | Direct |
| Mar 4, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Exercise | 10,679 | - | $0 | Direct |
| Mar 4, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Exercise | 5,650 | - | $0 | Direct |
| Mar 3, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Exercise | 5,179 | - | $0 | Direct |
| Dec 16, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Sale | 12,300 | $30.20 | $371,504 | Direct |
1-10 of 16 transactions